medikinet 5 mg tabletti
medice arzneimittel pÜtter gmbh & co. kg - methylphenidate hydrochloride - tabletti - 5 mg - metyylifenidaatti
medikinet 10 mg tabletti
medice arzneimittel pÜtter gmbh & co. kg - methylphenidate hydrochloride - tabletti - 10 mg - metyylifenidaatti
medikinet 20 mg tabletti
medice arzneimittel pÜtter gmbh & co. kg - methylphenidate hydrochloride - tabletti - 20 mg - metyylifenidaatti
attentin 5 mg tabletti
medice arzneimittel pÜtter gmbh & co. kg - dexamphetamine sulphate - tabletti - 5 mg - deksamfetamiini
attentin 10 mg tabletti
medice arzneimittel pÜtter gmbh & co. kg - dexamphetamine sulphate - tabletti - 10 mg - deksamfetamiini
attentin 20 mg tabletti
medice arzneimittel pÜtter gmbh & co. kg - dexamphetamine sulphate - tabletti - 20 mg - deksamfetamiini
apomorphine pharmascope 5 mg/ml infuusioneste, liuos, esitäytetty ruisku
pharmascope ltd. - apomorphine hydrochloride - infuusioneste, liuos, esitäytetty ruisku - 5 mg/ml - apomorfiini
efavirenz aurobindo 600 mg tabletti, kalvopäällysteinen
aurobindo pharma (malta) ltd - efavirenz - tabletti, kalvopäällysteinen - 600 mg - efavirentsi
zalviso
fgk representative service gmbh - sufentaniili - kipu, postoperatiivinen - anestesia- - zalviso on tarkoitettu aikuisille potilaille akuutin keskivaikean tai vaikean postoperatiivisen kipuun.
nucala
glaxosmithkline trading services - mepolizumab - astma - obstruktiivisten hengitystiesairauksien lääkkeet, - severe eosinophilic asthmanucala is indicated as an add-on treatment for severe refractory eosinophilic asthma in adults, adolescents and children aged 6 years and older. chronic rhinosinusitis with nasal polyps (crswnp)nucala is indicated as an add-on therapy with intranasal corticosteroids for the treatment of adult patients with severe crswnp for whom therapy with systemic corticosteroids and/or surgery do not provide adequate control. eosinophilic granulomatosis with polyangiitis (egpa)nucala is indicated as an add-on treatment for patients aged 6 years and older with relapsing-remitting or refractory eosinophilic granulomatosis with polyangiitis (egpa). hypereosinophilic syndrome (hes)nucala is indicated as an add-on treatment for adult patients with inadequately controlled hypereosinophilic syndrome without an identifiable non-haematologic secondary cause.